Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease

NCT02800070 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Fabry Disease

Interventions

BIOLOGICAL: Lentivirus Alpha-gal A transduced stem cells

Sponsor

University Health Network, Toronto

Collaborators

[object Object]